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Highlights
•Benzalkonium chloride (BAC) altered the antibiotic resistance profiles of bacteria in surface
water.

•BAC positively selected for bacteria resistant to ciprofloxacin and sulfamethoxazole.
•BAC selected against bacteria resistant to cephalexin, chloramphenicol, and streptomycin.
•Exposure to BAC over time showed increased relative abundance of the resistance
genes sul1 and blaTEM.

Abstract
Antibiotic resistance is a major public health concern. Triclosan is an antimicrobial compound with
direct links to antibiotic resistance that was widely used in soaps in the U.S. until its ban by the U.S.
Food and Drug Administration. Benzalkonium chloride (BAC), a quaternary ammonium compound, has
widely replaced triclosan in soaps marketed as an antibacterial. BAC has been detected in surface
waters and its presence will likely increase following increased use in soap products. The objective of
this study was to determine the effect of BAC on relative abundance of antibiotic resistance in a
bacterial community from a surface water used as a source for drinking water treatment. Bench-scale
microcosm experiments were conducted with microbial communities amended with BAC at
concentrations ranging from 0.1 μg L−1 to 500 μg L−1. Phenotypic antibiotic resistance was quantified by
culturing bacteria in the presence of different antibiotics, and genotypic resistance was determined
using qPCR to quantify antibiotic resistance genes (ARGs). BAC at concentrations ranging from 0.1
μg L−1 to 500 μg L−1 was found to positively select for bacteria resistant to ciprofloxacin and
sulfamethoxazole, and negatively select against bacteria with resistance to six other antibiotics.
Exposure to BAC for 14 days increased the relative abundance of sul1 and blaTEM. This study rehighlights the importance of employing both culture and non-culture-based techniques to identify
selection for antibiotic resistance. The widespread use of BAC will likely impact antibiotic resistance
profiles of bacteria in the environment, including in source waters used for drinking water, wastewater
treatment plants, and natural waterways.
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1. Introduction
Antibiotic resistance is a global health problem, and the World Health Organization warns that we
could soon enter a post-antibiotic era (World Health Organization, 2015). In the United States, over
23,000 people die each year from antibiotic resistant infections, and treating these infections costs an
estimated $1 billion per year (US Dept. of Health and Human Services, 2013). An estimated 10 million

people could die from antibiotic resistant infections globally by 2050 if no action is taken to reduce the
spread of antibiotic resistance (O’Neill, 2016). Since the proliferation of antibiotic resistance in the
environment could increase global antibiotic resistance that impacts public health, it is important to
understand what chemicals can potentially selecte for antibiotic resistance and how to mitigate their
effects.
Many chemicals apply selective pressure that can select for antibiotic resistance in the environment
(Gadea et al., 2017; Jutkina et al., 2018; Zhang et al., 2017, 2018). Antibiotics present a paradox
whereby the more we use them the less effective they become because bacteria continue to acquire
resistance (Barber, 2019). The use of antibiotics for medicinal and agricultural purposes leads to
increases in antibiotic resistance (Berendonk et al., 2015). Synthetic antimicrobial compounds used for
cleaning purposes have also been linked to antibiotic resistance (Tezel and Pavlostathis, 2015).
Triclosan, an antimicrobial, was widely used in hand soaps and is still used in toothpastes in the U.S.
and globally. Triclosan has been linked to increased tolerance to antibiotics and antibiotic resistance
genes (ARGs) in both pure culture studies and mixed microbial studies (Carey et al., 2016b; Carey and
McNamara, 2015, 2016; Liu and Han, 2008; McMurry, Oethinger, and Levy, 1998). Triclocarban is
another antimicrobial compound that was previously found to be in even higher abundance than
triclosan in U.S. biosolids (McClellan and Halden, 2010) and linked to selection for antibiotic resistance
(Carey et al., 2016a; Carey and McNamara, 2015) The link of triclosan and triclocarban to antibiotic
resistance along with their lack of benefit when added to hand soaps resulted in their ban from overthe-counter soaps in the U.S by the U.S. Food and Drug Administration (FDA) in 2016 (McNamara and
Levy, 2016).
Benzalkonium chloride (BAC) is an antimicrobial agent that was not included in the recent ban by the
U.S. FDA and is now widely used in hand soaps. BAC belongs to the class of quaternary ammonium
compounds which are often used as surfactants. BAC can be comprised of many different
alkylbenzyldimethylammonium chlorides with variable even-numbered alkyl carbon chain lengths
within the mixture. Exposure to BAC has been linked to increased selection for antibiotic resistance and
co-resistance to biocides and metals (Pal et al., 2015). For example, aerobic sediment communities
exposed to BAC had increased phenotypic resistance to ciprofloxacin (Tandukar et al., 2013). BAC
inevitably ends up in surface waters because it is a major consumer product (Clara et al.
2007a, b; Zhang et al., 2015) with the potential to enter drinking water treatment plants. Research on
antibiotic resistance in drinking water treatment plants and their distribution systems has been
increasing because of the direct exposure route of antibiotic resistance from drinking water to people
(Garner et al., 2018; Kappell et al., 2019; Xi et al., 2009; Xu et al., 2016) It is likely that BAC could impact
the antibiotic resistance profiles of bacteria and their genes in surface waters used for drinking water
treatment. Research is not available to describe how BAC alters antibiotic resistance in a source water
used for drinking water.
The objective of this research was to determine if BAC selects for antibiotic resistant bacteria and
resistance genes in a source water used for drinking water treatment. Based on previous sediment
research (Tandukar et al., 2013), it was hypothesized that BAC would increase phenotypic resistance to
ciprofloxacin, an important antibiotic for public health purposes. A surface water sample was collected
from Lake Michigan, a body of water used for several drinking water utilities, and amended with

varying levels of BAC. Phenotypic resistance to antibiotics was assessed through culture-based plating
techniques , and genotypic resistance was assessed through non-culture-based qPCR. This is the first
research to present information on the impacts of BAC on antibiotic resistance profiles in a source
water used for drinking water. These results provide insights into the possible ramifications of
widespread presence of BAC in the environment if it is to be used as widely as triclosan and
triclocarban were used.

2. Materials and methods
2.1. Reagents and supplies
A 50% w/w aqueous solution of BAC was manufactured by Alfa Aesar™ (Ward Hill, United States). The
BAC mix was comprised of benzyl-C8-18-alkyldimethyl chlorides from C8 to C18 carbon chain lengths.
Product specifications indicate water content to be > 48.0 to <52.0% (Cat No. AAB20760AP, Mfr No.
B20760AP). Ampicillin sodium salt (VWR, Cat No. 97061-442) was dissolved in Milli-Q® water at
32 mg mL−1 and filter sterilized. Chloramphenicol ≥98% (Sigma Life Science, Product No. C0378) was
dissolved in 100% ethanol at 32 mg mL−1. Sulfamethoxazole (Sigma-Aldrich, Product No. S7507) was
dissolved in acetone at 100 mg mL−1. Erythromycin (Sigma-Aldrich, Product No. E6376) was dissolved in
100% ethanol at 8 mg mL−1. Streptomycin sulfate salt (Sigma-Aldrich, Product No. S6501) was dissolved
in Milli-Q® water at 64 mg mL−1 and filter sterilized. Rifampicin (TCI America, Product No. R0079) was
dissolved in dimethyl sulfoxide at 4 mg mL−1. Ciprofloxacin ≥98.0% (Sigma-Aldrich, Product No. 17850)
was dissolved in Milli-Q® water and one drop 5N hydrochloric acid at 4 mg mL−1 and filter sterilized.
Trimethoprim (TCI America, Product No. T2286) was dissolved in dimethyl sulfoxide at 16 mg mL −1.
Tetracycline HCl (Research Products International, Cat No. T17000) was dissolved in Milli-Q® water at
10 mg mL−1 and filter sterilized. Cephalexin monohydrate (Research Products International, Cat No.
C59000) was dissolved in Milli-Q® water at 8 mg mL−1 and filter sterilized. Ultra-pure grade
cycloheximide crystalline was obtained from VWR International (Cat No. 97064-724) and prepared in
Milli-Q® water at 100 mg mL−1 and filter sterilized. Dimethyl sulfoxide ≥99.9% was obtained from
Sigma-Aldrich (Product No. 472301). 100% ethanol was obtained from VWR International (KOPTEC, Cat
No. 89125-186). HPLC grade acetone was obtained from Fisher Scientific (Fisher Chemical, Cat No.
A949-1). Molecular genetics grade agar powder was purchased from Fisher Scientific (Fisher
BioReagents™, Cat No. BP1423-500). R2A Broth for heterotrophic bacteria was purchased from VWR
(HiMedia®, Cat No. 95039-342).

2.2. Microcosm setup
Microcosms were used to analyze the effect of BAC on the phenotypic and genotypic resistance of the
bacterial community. Water was sampled from the outer harbor of Lake Michigan in Milwaukee,
Wisconsin and aseptically aliquoted into 1 L sterile clear glass bottles with 125 mL headspace. Bottles
were amended with BAC at concentrations of 0, 0.1, 1.0, 10, 100, or 500 μg L −1. Concentrations were
based on BAC concentrations present in the environment in surface waters (1.9 μg L −1), wastewater
treatment influent (0.810–170 μg L−1), wastewater treatment effluent (0.014–0.630 μg L−1), hospital
effluent (4000 μg L−1), and known bacterial minimum inhibitory concentrations (MIC’s) to BAC (40012,000 μg L−1) (Clara et al. 2007a, b; Lambert et al., 2001; Joynson et al., 2002; Loughlin et al.,
2002; Martínez-Carballo et al., 2007). BAC is currently an active ingredient in many anti-bacterial
consumer products at a concentration of 1.3 × 106 μg L−1 and becomes diluted in the wastewater

treatment train and subsequent processes. The control community was not amended with BAC. BAC
was added by diluting with Milli-Q® water as a vehicle for the chemical compound. Each microcosm
treatment condition was tested in triplicate (n = 3). Bottles were loaded onto an orbital mixer at
125 rpm to suspend cells and ensure continuous mixing. The bottles were kept at room temperature
(20 ± 2.0 °C) and covered to mitigate light and the growth of phototrophs (Wang et al., 2012). Agar
plates were prepared with 10 distinct antibiotics. Water samples from each microcosm bottle were
directly plated onto the agar plates on days 0, 3, 7, and 14 with and without antibiotics to quantify
phenotypic antibiotic resistance. For day 0, water samples were aliquoted into three sterile 1 L bottles
and directly plated on the same day with no treatment added. Water from source water (day 0) and
remaining volume of microcosms from day 14 were filtered, extracted for DNA, and analyzed for ARGs
via qPCR.

2.3. Quantification of antibiotic resistant heterotrophic bacteria
The quantification of total and antibiotic resistant heterotrophic bacteria was determined by direct
plating onto R2A growth media with or without antibiotics and with 100 μg mL −1 of cycloheximide to
inhibit fungal growth. Antibiotic concentrations included: ampicillin (AMP; 32 μg mL −1),
chloramphenicol (CHL; 32 μg mL−1), sulfamethoxazole (SULF; 100 μg mL−1), erythromycin (ERY;
8 μg mL−1), streptomycin (STREP; 64 μg mL−1), rifampicin (RIF; 4 μg mL−1), ciprofloxacin (CIP; 4 μg mL−1),
trimethoprim (TRIM; 16 μg mL−1), tetracycline (TET; 16 μg mL−1), and cephalexin (CEPH; 8 μg mL−1). The
implementation of these agar plates with different antibiotics is a well-established method in our lab
(Kappell et al., 2019) and in literature (Nagy et al., 2015; Watkinson et al., 2007). Concentrations were
diagnostic concentrations inferring failure of treatment or clinical resistance based on CLSI dilution
method (CLSI, 2018). A variety of antibiotics were used to represent various classes and uses which are
pertinent to human health, although some of the most widespread antibiotics found in the
environment are erythromycin, streptomycin, and trimethoprim (Gothwal and Shashidhar, 2015). A
table listing the various classes of antibiotics tested is provided in Supplemental Table S2. Samples
were spread plated onto agar media prior to incubation at 30 °C for 5 days. Based on resulting counts,
water samples were diluted at 100, 10−1, 10−2, 10−3, 10−4, and 10−5 and adjusted accordingly in order to
yield countable (30–300) results. Counts were performed manually (Braoudaki and Hilton, 2004).

2.4. DNA extraction
DNA was extracted from filters used to capture DNA in the experiments. Specifically, water from all
microcosms were harvested on day 14 (615–1000 mL) and aseptically quantified using a sterile clear
glass graduated cylinder. The water was aseptically filtered through 0.2-μm polycarbonate filters, and
the filters were stored in sterile 2 mL tubes at −20 °C prior to extraction. In addition, three 1 L samples
were harvested on day 0 and filtered onto 0.2-μm polycarbonate filters, and the filters were stored
at −20 °C prior to extraction. DNA extractions on the filters were performed per manufacturer
instructions with the FastDNA Spin Kit (MP Biomedicals LCC, Solon, OH). Filters were initially broken by
grinding with sterile pipet tips after tubes were exposed to liquid nitrogen. After addition of CLS-TC
buffer, initial cell lysis was performed by subjecting the filters to three freeze-thaw cycles with liquid
nitrogen followed by incubation at room temperature for 30 min (Kappell et al., 2019; McNamara
et al., 2014). The filters were subjected to freeze-thaw cycles to ensure sufficient cell breakage. DNA
yield was quantified by spectrophometric analysis with Nanodrop.

2.5. Quantification of antibiotic resistance genes
Quantitative polymerase chain reactions (qPCR) were performed using a LightCycler 96 (Roche Applied
Science). All reactions were a total volume of 20 μL and utilized 1X PowerUp™ SYBR® Green Master
Mix (Applied Biosystems, Cat No. A25741), primers at a final concentration of 1.0 μM each, and 5 μL
DNA diluted 1:50 to minimize inhibition in the optimal range for the target gene standard curve. All
qPCR were performed under the following conditions: preincubation (50 °C, 120s), preincubation and
initial denaturation (95 °C, 600s), three-step amplification (95 °C, 30s; annealing temperature specific
to target gene, 30s; 72 °C, 30s; 40 cycles), followed by melting curve analysis. The target genes
included: 16S rRNA, intI1, sul1, and blaTEM. The quantification of the 16S rRNA gene was used to
enumerate members of the domain Bacteria (LaPara et al., 2011). The integrase gene of the class 1
integron, intI1, was quantified because it is related to horizontal gene transfer and has been used as a
proxy for anthropogenic pollution in the environment (Gillings et al., 2008, 2015). The sul1 gene
confers resistance to sulfonamides, synthetic antimicrobial agents (Gao et al., 2012; Heuer et al.,
2011; Pruden et al., 2006). Finally, the blaTEM gene confers resistance to β-lactams which is a major
public health concern and many antibiotics including ampicillin and cephalexin belong to this category
(Livermore, 1995; Poole, 2004). Each DNA sample was subjected to qPCR in triplicate and the copy
numbers (CN) per L from the three wells were averaged. Acceptable R2 values were greater than 0.98
and acceptable efficiency averages were greater than 84.5%.

2.6. Statistical analysis
Statistical analysis was performed using the statistical package ‘R’ within ‘R Studio’ (Team R
Development Core, 2011). Significant differences between BAC treatment concentrations and time of
exposure for absolute and relative abundance of antibiotic resistant bacteria (ARB) and ARGs was
determined using one-way analysis of variance (ANOVA) with the ‘aov’ function. Post-hoc multiple
pairwise comparisons were performed with Tukey’s honestly significant differences (HSD)
implemented with the ‘TukeyHSD’ function. Significant differences were defined as p-values less than
0.05.

3. Results and discussion
3.1. Impact of BAC on bacterial phenotypic selection for antibiotic resistance
A source water was amended with varying concentrations of BAC and sampled over time. To assess
impacts of BAC on antibiotic resistance, the phenotypic resistance profiles of BAC-amended
communities were compared to the control community at the same time point (Fig. 1) and compared
to themselves over time (Fig. 2). The relative abundance of bacteria resistant to ciprofloxacin was
significantly greater when exposed to 0.1 μg L−1 BAC by day 7 compared to the control with no
exposure (p = 0.011). This finding is relevant because ciprofloxacin is currently used to treat a variety of
bacterial infections, including severe cases of typhoid fever in children and in chronic typhoid carriers,
and is a very important antibiotic for protection of public health (Ferreccio et al., 2019; Dutta et al.,
1993). Ciprofloxacin was found to more frequently exceed safe levels in rivers globally than any other
antibiotic tested in a recent international study (Wilkinson et al., 2019), and was the most abundant
antibiotic found in a U.S. survey of biosolids (McClellan and Halden, 2010). The high prevalence of
ciprofloxacin reflects its high usage rates, but has also triggered concerns due to its links in promoting
cross-resistance. In a recent study with human-associated, wastewater-derived bacterial communities

ciprofloxacin was often associated with multidrug resistance (Murray et al., 2019). Cross resistance to
ciprofloxacin was also seen in anaerobic digester biomass exposed to triclosan (Carey and McNamara,
2016) corroborating the findings of this research that an antimicrobial, in this case BAC, has potential
to lead to cross resistance to ciprofloxacin. Note that the relative abundance of bacteria resistant to
ciprofloxacin in the BAC-amended communities were not different from the control at day 3 or day 14
(p > 0.05), indicating that selection for antibiotic resistance is transient (Kappell et al., 2019).

Fig. 1. Impact of BAC (0.1, 10, and 500 μg L−1) relative to control (0 μg L−1) on phenotypic resistance to 10
antibiotics in the bacterial community of a source water for drinking water treatment. Bars represent average
log-scaled relative abundance of antibiotic resistant bacteria (ARB) relative to total heterotrophic plate counts
(THC) among three plates. A higher bar represents more bacterial colonies resistant to the associated antibiotic
normalized to all bacterial colonies grown without the presence of an antibiotic. An * refers to a statistical
increase or decrease (p < 0.05) compared to 0 μg L−1 BAC. Error bars represent standard deviation of the three
relative abundances from ARB relative to THC (n = 3). Total abundance including R2A counts are included in
SI Fig. 1.

Fig. 2. Impacts of BAC on phenotypic resistance to 10 antibiotics in the bacterial community of a source water
for drinking water treatment. Relative abundance of phenotypic resistance is shown over time relative to initial
conditions (day 0) for the given concentration of BAC (a = 0 μg L−1, b = 0.1 μg L−1, c = 10 μg L−1, d = 500 μg L−1).
Relative abundance of antibiotic resistant bacteria (ARB) at day 0 is the same for all communities. Solid colored
circles in legend refer to a statistical increase (p < 0.05) and open circles refer to a statistical decrease between
the relative abundance of ARB on days 3, 7, and 14 compared to day 0 for the given BAC concentration. Bars
represent average log-scaled relative abundance of ARB to total heterotrophic plate counts (THC) among three
plates. A higher bar represents more bacterial colonies resistant to the associated antibiotic normalized to all
bacterial colonies grown without the presence of an antibiotic. Error bars represent standard deviation of the
three relative abundances from ARB relative to THC (n = 3).

Phenotypic resistance to ampicillin, streptomycin, and rifampicin of heterotrophic bacteria exposed to
0.1 μg L−1 BAC significantly decreased by day 3 (p < 0.031). Similarly, resistance to erythromycin,
trimethoprim, and tetracycline of the community exposed to 500 μg L−1 BAC significantly decreased by
day 14 (p < 0.008). This finding is relevant because erythromycin, streptomycin, and trimethoprim are
some of the most widespread antibiotics found in the environment (Gothwal and Shashidhar, 2015).
Since BAC negatively selected for bacteria resistant to these antibiotics, it should be noted that BAC, at
least in part, has potential to limit the proliferation of antibiotic resistance to a select few antibiotics at
the concentrations tested. Erythromycin, streptomycin, and trimethoprim all treat various bacterial
infections that are pertinent to human health and the impact BAC exposure has on a bacterial
community used as a source water for drinking water treatment should be tested further to identify
negative selection potential.

Analysis of how the antibiotic resistance profiles changed over time for a given community reveal
distinct trends in the control community and BAC-amended communities. Exposure to 0.1 μg L−1 BAC
led to increased abundance of phenotypic resistance to sulfamethoxazole and ciprofloxacin (Fig. 2b).
The relative abundance of bacteria resistant to sulfamethoxazole increased by day 3 for both
communities (p < 0.005), but the relative abundance of ARB to sulfamethoxazole only significantly
increased on day 7 and day 14 compared to day 0 in the community treated with 0.1 μg L −1 BAC
(p < 0.006). These increases were not observed for the control community on day 7 and 14 (p > 0.242).
Relative abundance of ARB at day 0 is the same for both communities. The relative abundance of ARB
significantly increased by day 7 for ciprofloxacin when the community was treated with 0.1 μg L −1 BAC
(p < 0.001). No significant increases to ciprofloxacin were observed for any days in the control
community (p > 0.999). Overall, addition of BAC showed potential for more increases in relative
abundance of ARB and selection for phenotypic resistance to sulfamethoxazole and ciprofloxacin than
no addition of BAC. This finding is relevant because sulfamethoxazole and ciprofloxacin are currently
used to treat a variety of bacterial infections. For example, sulfamethoxazole is used to treat cases of
pneumonia and patients with human immunodeficiency virus (Thomas and Limper, 2014). In addition,
BAC-fed bioreactors have been shown to select for the opportunistic pathogen Pseudomonas
aeruginosa and select for ARB (Kim et al., 2018). While the data shown here make it clear that BAC will
not universally select for antibiotic resistance to all antibiotics, the selection for resistance to
ciprofloxacin and sulfamethoxazole is a potential concern and warrants further study.
Exposure to BAC also led to decreased resistance to other antibiotics (Fig. 2b). Exposure to
0.1 μg L−1 BAC decreased phenotypic resistance to ampicillin, streptomycin, and rifampicin by day 3.
Over time, there were also observed increases in phenotypic resistance in the control community
without exposure to BAC for ampicillin, chloramphenicol, streptomycin, rifampicin, trimethoprim, and
cephalexin that did not occur when exposed to 0.1 μg L−1 BAC. For the control community, the relative
abundance of ARB increased by day 3 for all six antibiotics listed (p < 0.043) and increased by days 7
and 14 for rifampicin, trimethoprim, and cephalexin (p < 0.048). No increases in relative abundance
were observed over time for these six antibiotics when the community was treated with 0.1 μg L −1 BAC
(p > 0.056). Therefore, addition of BAC at 0.1 μg L−1 concentration suppressed these increased
phenotypic resistance trends. With no BAC added, there were significant increases in relative
abundance of ARB that were no longer present when BAC was added to the community. BAC clearly
affects antibiotic resistance profiles of bacteria, but not in the same way for all antibiotics. In this case,
BAC increased selection for bacteria resistant to sulfamethoxazole and ciprofloxacin, and decreased
selection for bacteria resistant to ampicillin, chloramphenicol, streptomycin, rifampicin, trimethoprim,
and cephalexin. Phenotypic resistance to erythromycin increased on all days in both the communities
exposed to BAC at 0.1 μg L−1 and the communities not exposed to BAC.
At 10 μg L−1 BAC, increases in phenotypic resistance to sulfamethoxazole, ciprofloxacin, and
streptomycin were observed that did not occur in the control community (Fig. 2c). Relative abundance
of bacteria resistant to both sulfamethoxazole and streptomycin increased on days 3, 7, and 14 when
exposed to 10 μg L−1 BAC (p < 0.015). The increased phenotypic resistance profiles to sulfamethoxazole
were the same for the 10 μg L−1 BAC treatment condition as they were for the 0.1 μg L−1 BAC treatment
condition. Exposure to 10 μg L−1 BAC also increased phenotypic resistance to ciprofloxacin on day 3 and
day 14 (p < 0.036). ARB in the control community demonstrated increased resistance to

sulfamethoxazole and streptomycin by day 3 (p < 0.016) and were not statistically different on day 7
and day 14 (p > 0.242). There were no increases in relative abundance of ARB to ciprofloxacin in the
control community. The addition of BAC at 10 μg L−1 BAC increased selection of resistance to all three
antibiotics by day 3 and day 7. This finding is relevant because streptomycin is currently used to treat a
variety of bacterial infections, including tuberculosis (Sotgiu et al., 2015). Tuberculosis is the second
leading cause of death from an infectious disease worldwide, and is a very important antibiotic for
protection of public health especially since many tuberculosis strains can acquire multi-drug
resistances (Pham et al., 2015).
Exposure to BAC at 10 μg L−1 decreased phenotypic resistance to ampicillin, chloramphenicol,
rifampicin, and trimethoprim. Similar to trends with 0.1 μg L−1 BAC exposure, statistical increases over
time of relative abundance of ARB resistant to ampicillin, chloramphenicol, rifampicin, and
trimethoprim were present with no BAC (p < 0.048). These increases were not observed for the
10 μg L−1 BAC treatment condition. Exposure to BAC did not impact phenotypic resistance to
erythromycin or cephalexin since there were increases on all three days present in both communities
(p < 0.002).
Relative abundance of ARB resistant to tetracycline showed significant decreases over time in the
control community with no BAC by day 3 and day 7 (p < 0.033) and a significant increase on day 14
(p < 0.001). However, these decreases were not present in the community exposed to 10 μg L −1 BAC
(p > 0.583). Thus, the addition of BAC allowed the community to maintain resistance to tetracycline by
day 14 and eliminated decreases by day 3 and day 7.
Exposure to 500 μg L−1 BAC resulted in the same trend as 0.1 and 10 μg L−1, i.e. phenotypic resistance
to sulfamethoxazole and ciprofloxacin increased (Fig. 2d). Relative abundance of ARB resistant to both
sulfamethoxazole and ciprofloxacin increased on days 3 and 7 when exposed to 500 μg L −1 BAC
(p < 0.019). In the control community, the relative abundance of ARB resistant to sulfamethoxazole
increased by day 3 (p = 0.005). The increased phenotypic resistance profiles to sulfamethoxazole on
day 3 and day 7 were the same for the 500 μg L−1 BAC treatment condition as they were for the 0.1 and
10 μg L−1 BAC treatment conditions. There were no significant increases in phenotypic resistance to
ciprofloxacin over time in the control community with no BAC. For the 500 μg L −1 BAC treatment
condition, increased phenotypic resistance to ciprofloxacin was observed at day 3 and day 7
(p < 0.018). The increased phenotypic resistance profiles to ciprofloxacin on day 3 were the same for
the 10 μg L−1 BAC treatment condition and on day 7 was the same for the 0.1 μg L −1 BAC treatment
condition. The addition of BAC at 500 μg L−1 in the community positively selected for phenotypic
resistance to both sulfamethoxazole and ciprofloxacin.
Exposure to BAC at 500 μg L−1 decreased phenotypic resistance to chloramphenicol, streptomycin,
rifampicin, trimethoprim, and tetracycline. Similar to trends with 0.1 and 10 μg L −1 BAC exposure,
statistical increases over time of relative abundance of ARB resistant to all five antibiotics listed were
present in the control community (p < 0.048). These increases, mostly on day 3, were not present with
the 500 μg L−1 BAC treatment condition. Following the same trend as 10 μg L−1 BAC, at 500 μg L−1 BAC
treatment did not impact phenotypic resistance to erythromycin or cephalexin since there was a
statistical increase all three days present in both control and treated communities (p < 0.012).

Furthermore, 500 μg L−1 BAC treatment did not impact phenotypic resistance to ampicillin since there
was a statistical increase by day 3 present in both communities (p < 0.043).
Relative abundance of ARB resistant to chloramphenicol and tetracycline significantly decreased over
time in the control community by day 7 (p < 0.002). However, these decreases were not present in the
community exposed to 500 μg L−1 BAC (p > 0.956). Thus, exposure to BAC altered the community
antibiotic resistance profiles and eliminated decreases in relative abundance in ARB to
chloramphenicol and tetracycline by day 7.

3.2. Impact of BAC on bacterial genotypic selection for antibiotic resistance
No statistically significant increases in ARGs compared to 0 μg L−1 BAC treatment were observed via
qPCR on day 14 (p > 0.05) (Fig. 3). When compared to the initial day 0 source water sample, however,
relative abundance of sul1 and blaTEM showed significant increases when exposed to 500 μg L−1 BAC.
Interestingly, relative abundance of sul1 increased significantly from day 0 to day 14 when exposed to
10 and 500 μg L−1 BAC (p = 0.011) and did not significantly increase in the no treatment control.
Similarly, relative abundance of blaTEM increased significantly from day 0 to day 14 when exposed to
500 μg L−1 BAC (p = 0.030) and did not significantly increase in the no treatment control. This result is
relevant since the sul1 gene confers resistance to sulfonamides, synthetic antimicrobial agents (Gao
et al., 2012; Heuer et al., 2011; Pruden et al., 2006), and the blaTEM gene confers resistance to βlactams which is represented in numerous antibiotics and is a major public health concern (Livermore,
1995; Poole, 2004).

Fig. 3. The effect of BAC on relative abundance of the genes intI1, sul1, and blaTEM. Bars represent average logscaled relative gene copy values relative to total 16S rRNA gene copies. A higher bar signifies more relative gene
copies and a greater quantity of resistance genes in the given sample. Error bars represent standard deviation of
triplicate qPCR assays for each microcosm sample (n = 3). A black * denotes statistical significance (p < 0.05)
compared to control of 0 μg L−1 BAC. Each BAC concentration from 0 to 500 μg L−1 was harvested at day 14 after
exposure to the BAC treatment. An orange * denotes statistical significance (p < 0.05) compared to initial time
control at day 0. (For interpretation of the references to color in this figure legend, the reader is referred to the
Web version of this article.)

Relative abundance gives insight into acquired resistance. Absolute abundances gives information into
the total quantity of gene copies per liter of sample water which can be relevant when calculating risk.
Absolute abundances of all genes are provided in Supplemental Fig. 3. The absolute abundance
of sul1 significantly increased for all concentrations of BAC compared to day 0. The absolute
abundance of blaTEM significantly increased compared to day 0 when exposed to BAC at 0.1 μg L−1 and
500 μg L−1.
When exposed to BAC treatment conditions, resistance to antibiotics was observed in viable cells
phenotypically and showed different resistance trends with a genotypic approach over time. Acquired
resistance is better to detect phenotypically because it indicates actual resistance is conferred. In
addition, phenotypic resistance is medically relevant since it shows culturable results from bacteria
that acquired antibiotic resistance as a result of BAC exposure. Culture-dependent techniques are

valuable because they reveal resistance that may be difficult to quantify using molecular techniques
such as qPCR. A limitation to culturable methods is that only a fraction of a bacterial community can be
cultured. Both methods are necessary to tell a holistic story as molecular methods indicate broader
potential for acquisition of antibiotic resistance. Molecular methods, such as qPCR, are required to
detect resistance determinants in the community that could be relevant to public health in strains not
accounted for by heterotrophic culture-dependent methods (Boolchandani et al., 2019). A limitation to
this study is that metagenomics and metatranscriptomics were not conducted to quantify changes in
total known ARG quantities and active expression of genes. Future work on this topic should use RNA
to detect active expression of antibiotic resistance, including metatranscriptomics.

4. Environmental implications
Due to the recent ban on triclosan and triclocarban, replacement with BAC in consumer products
warrants further study. As demonstrated in this study, BAC could lead to potential shifts in antibiotic
resistance profiles in the environment. This study indicates that BAC alters resistance profiles to nine
medically relevant antibiotics including ampicillin, chloramphenicol, sulfamethoxazole, streptomycin,
rifampicin, ciprofloxacin, trimethoprim, tetracycline, and cephalexin. BAC positively selected for
bacteria resistant to sulfamethoxazole and ciprofloxacin at three concentrations of BAC. The relative
abundance of ARB resistant to sulfamethoxazole and ciprofloxacin significantly increased when BAC
was present. This trend was not present in the control community with no BAC. This finding is
important since exposure to BAC has led to cross-resistance with fluoroquinolones, the antibiotic class
in which ciprofloxacin belongs (Jolivet-Gougeon et al., 2015). BAC also selected for antibiotic resistance
genes sul1 and blaTEM in exposed communities over time. Conversely, BAC negatively selected for
bacteria resistant to ampicillin, streptomycin, and rifampicin at 0.1 μg L −1 BAC, and negatively selected
for bacteria resistant to erythromycin, trimethoprim, and tetracycline at 500 μg L −1 BAC. It should be
noted that BAC has potential to limit the proliferation of antibiotic resistance to certain antibiotics in
the environment at the specific concentrations and conditions tested. Since BAC can both positively
and negatively select for ARB in the environment, further research is necessary to determine the
impact of BAC on surface waters, especially if the concentration of BAC in environmental waters
increases. BAC has recently been used as an alternative to both triclosan and triclocarban as an
antimicrobial agent in consumer products. Both triclosan and triclocarban have been linked to the
proliferation of antibiotic resistance in wastewater treatment processes (Carey et al., 2016a,b; Carey
and McNamara, 2015; Carey and McNamara, 2016; Liu and Han, 2008; McClellan and Halden,
2010; McMurry et al., 1998). BAC also has the potential to select for antibiotic resistance in other
environments, including wastewater biosolids, and important biological wastewater treatment
processes such as activated sludge and anaerobic digestion (Baquero et al., 2008; Clara et al. 2007a, b).
It is clear that BAC has the potential to alter antibiotic resistance profiles, specifically phenotypic
resistance. Culture-dependent techniques are valuable for the ability to detect changes in phenotypic
resistance in addition to potential for resistance observed from genotypic differences over time.
Further study on the impact of BAC on antibiotic resistance is necessary to fully understand
mechanisms of resistance in the environment and active expression of resistance genes.
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